November 21st, 2006
The good news that Herceptin® (trastuzumab) (the world’s first targeted therapy) is now available for many women with early-stage HER2-positive breast cancer, marks a significant advancement in breast cancer management.
According to Edith Perez, M.D., director of Mayo Clinic’s Breast Clinic in Jacksonville, Florida:
“…signifies the importance for women who are newly diagnosed with breast cancer to […]
By Gloria Gamat -- 0 comments
November 8th, 2006
Administering less radiation than usual is just as effective against a benign but potential devastating brain tumor called an acoustic schwannoma and might save more of the patient’s hearing.
Such were the recent findings of radiation oncologists at the Kimmel Cancer Center at Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia.
Acoustic schwannoma is a […]
By Gloria Gamat -- 0 comments
September 14th, 2006
U.S. researchers have recently reported that in children with brain tumors called medulloblastomas, a highly targeted treatment that relies on the patient’s own stem cells led to improved outcomes: from 30-40% chance of surviving to five years to 70-80%.
Chemotherapy usually lasts for 12 months. In this new treatment regimen, radiation therapy is tailored to the […]
By Gloria Gamat -- 0 comments
September 3rd, 2006
According to a study from the University of Rochester Medical Center, people routinely exposed to lead in their jobs are 50% more likely to die from brain cancer that those who are not exposed.
According to the American Cancer Society, little is known about the causes of brain cancer with only radiation as the established link […]
By Gloria Gamat -- 0 comments
Recent Comments